Lifestyle program for metastatic prostate cancer on hormone therapy
Part of Cancer, Kidney & urinary clinical trials.
This trial studies whether a structured lifestyle intervention (such as exercise and related behavior changes) can benefit people with metastatic prostate cancer who are currently on hormone treatment. It may help by improving health and functioning while you continue standard cancer therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and can sign a consent form for the study.
- Your prostate cancer is confirmed as adenocarcinoma (the most common prostate cancer type).
- You are currently taking hormone therapy (ADT alone or ADT plus a common add-on medicine like abiraterone, enzalutamide, apalutamide, or darolutamide).
- Your PSA (a blood marker) is rising compared with your lowest point, but scans show no clear disease progression yet.
- Your PSA is rising slowly enough that your PSA doubling time is more than 8 weeks.
- You have not been on certain other cancer treatments recently (like docetaxel/cabazitaxel, radiation to the whole body, or investigational drugs).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a structured exercise program can help men with metastatic prostate cancer who are on hormone therapy. It looks at changes in cancer cells and overall well-being.
This trial tests a digital exercise program to see if it helps men with prostate cancer stay active while on hormone therapy. You may be able to join if you're starting or already on hormone therapy and also getting radiation therapy.
This study tests whether a supervised exercise program can help men with prostate cancer stay stronger and feel better during combined radiation and hormone therapy. You may be able to join if you are about to start these treatments and are otherwise healthy enough to exercise.
This trial tests a structured resistance training program for men with prostate cancer who are on hormone therapy. The goal is to see if the exercise program helps maintain muscle strength and improve quality of life during treatment.
This study tests whether a supervised exercise program can help reduce heart disease risk in men with prostate cancer who are on hormone therapy. Participants will exercise at home or in a group and be monitored for heart health changes.
This study tests whether a supervised exercise program can help manage side effects like fatigue and muscle loss when starting hormone therapy for prostate cancer. Participation may improve your quality of life during treatment.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.